Lymphoma  >>  dexamethasone  >>  Phase 3
Welcome,         Profile    Billing    Logout  

21 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dexamethasone / Generic mfg.
NCT00000658: A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

Completed
3
250
US
Bleomycin sulfate, Vincristine sulfate, Doxorubicin hydrochloride, Cyclophosphamide, Allopurinol, Methotrexate, Cytarabine, Leucovorin calcium, Sargramostim, Dexamethasone
National Institute of Allergy and Infectious Diseases (NIAID), Schering-Plough
Lymphoma, Non-Hodgkin, HIV Infections
 
02/96
NCT00039910: Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Completed
3
240
US, Europe, RoW
(PN-152,243)/ PN-196,444
Pfizer
Non-Hodgkin Lymphoma, Hodgkin Disease, Thrombocytopenia
 
03/03
HOVON-44, NCT00012051: Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Completed
3
340
Europe
filgrastim, rituximab, carmustine, cisplatin, cytarabine, dexamethasone, etoposide, ifosfamide, melphalan, methotrexate, bone marrow ablation with stem cell support, peripheral blood stem cell transplantation, radiation therapy
Commissie Voor Klinisch Toegepast Onderzoek
Lymphoma
 
10/07
NCT00137995: R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma

Checkmark P3 data
Mar 2012 - Mar 2012: P3 data
Checkmark P3 data in DLBCL
Nov 2011 - Nov 2011: P3 data in DLBCL
Completed
3
481
Europe, US, RoW
Rituximab, R, Etoposide, Carboplatine, Ifosfamide + Mesna, Cisplatine, Cytosine Arabinoside, Dexamethasone, Autologous Stem Cell Transplantation, ASCT, BCNU, BICNU, Cytarabine, Melphalan
Lymphoma Study Association
Lymphoma, Large-Cell, Diffuse
10/08
10/08
NCT00003650: Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma

Completed
3
179
Europe
asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, etoposide, mercaptopurine, methotrexate, methylprednisolone, mitoxantrone hydrochloride, prednisone, vincristine sulfate, radiation therapy
UNICANCER
Lymphoma
12/08
11/13
B1931006, NCT00562965 / 2007-000219-27: Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)

Checkmark P3 data - EHA
Jun 2012 - Jun 2012: P3 data - EHA
Terminated
3
29
US, Canada, Europe, RoW
inotuzumab ozogamicin, rituximab, cyclophosphamide, vincristine, prednisone/prednisolone, mitoxantrone, fludarabine, dexamethasone
Pfizer, UCB Pharma
Lymphoma, Follicular
04/11
04/11
LY.12, NCT00078949: Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Completed
3
849
Canada, US, RoW
rituximab, cisplatin, cytarabine, dexamethasone, gemcitabine hydrochloride
NCIC Clinical Trials Group
Lymphoma
07/13
12/18
NCT00003639: Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

Unknown status
3
200
Europe
recombinant interferon alfa, chlorambucil, dexamethasone, idarubicin
Scotland and Newcastle Lymphoma Group
Lymphoma
 
 
NCT00006250: Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma

Unknown status
3
500
Europe
chlorambucil, dexamethasone, fludarabine phosphate, mitoxantrone hydrochloride
Lymphoma Trials Office
Lymphoma
 
 
NCT00003423: Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma

Unknown status
3
100
Europe
asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, etoposide, mercaptopurine, methotrexate, prednisolone, thioguanine, vincristine sulfate
United Kingdom Children's Cancer Study Group
Lymphoma
 
 
EU-MCL younger, NCT00209222: Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL

Checkmark P3 data- ASH 2012
Nov 2012 - Nov 2012: P3 data- ASH 2012
Checkmark P3 data release
Jun 2011 - Jun 2011: P3 data release
Unknown status
3
360
Europe
Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Cisplatinum, Ara-C, Dexamethasone, BCNU, Melphalan, Etoposide, G-CSF, chemotherapy: R-CHOP, chemotherapy: R-DHAP, chemotherapy: Dexa-BEAM, stem cell harvest, total body irradiation, high-dose chemotherapy: Cyclophosphamide, high-dose chemotherapy: Ara-C /Melphalan
European Mantle Cell Lymphoma Network, German Low Grade Lymphoma Study Group, Lymphoma Study Association
Lymphoma, Mantle-Cell
12/14
12/14
2007-005396-34: Treatment Protocol for T-Cell and B-Precursor Cell Lymphoblastic Lymphomaof the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma (EICNHL)

Completed
3
20
Europe
dexamethasone, prednisolone, methotrexate, mercaptopurine, methylprednisolone, dexamethasone, prednisolone, methotrexate, mercaptopurine, methylprednisolone, dexamethasone, prednisolone, methotrexate, mercaptopurine, methylprednisolone
University of Birmingham
lymphoblastic lymphoma
 
12/08
NCT01788020 / 2013-000506-37: Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia

Completed
3
202
Europe
Dexamethasone, Rituximab, Cyclophosphamide, Dexamethasone, Rituximab, Cyclophosphamide, Bortezomib
University of Ulm, Centre Hospitalier de Lens (Co-Sponsor)
Waldenström's Macroglobulinemia
11/18
04/24
NCT03623087: SIMPLE Chemotherapy for NK Lymphoma/Leukaemia

Unknown status
3
68
RoW
Cisplatin, Gemcitabine, Etoposide (VP-16), Ifosfamide, Dexamethasone, L-asparaginase
The University of Hong Kong
Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin T-cell Lymphoma, Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
03/20
06/20
NCT02631239: MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma

Active, not recruiting
3
256
RoW
Methotrexate, Etoposide, Dexamethasone, Pegaspargase, Radiotherapy
Ruijin Hospital
Extranodal NK/T-cell Lymphoma, Nasal Type
03/21
07/22
Uni-Koeln-1762, NCT02661503 / 2014-005130-55: HD21 for Advanced Stages

Active, not recruiting
3
1500
Europe
Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, Prednisone, Brentuximab Vedotin, Dacarbazine, Dexamethasone
University of Cologne
Classical Hodgkin Lymphoma
12/22
09/25
NCT02085655: PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma

Recruiting
3
264
RoW
pegaspargase, Oncaspar, Gemcitabine, Gemzar, Oxaliplatin, Eloxatin, Methotrexate, Dexamethasone, Thalidomide
Huiqiang Huang, Sun Yat-sen University
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
12/22
12/22
NCT00199108: Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in Central Nervous System With Depocyt

Completed
2/3
20
Europe
Depocyt, Dexamethasone
Goethe University
Adult Acute Lymphocytic Leukemia
06/08
06/08
2010-021091-28: A clinical study to determine whether a new drug masitinib is safe and effective in cancer of the white blood cells.

Ongoing
2/3
267
Europe, RoW
Masitinib mesylate, Gemcitabine, Dexamethasone, AB1010, Film-coated tablet, Powder for infusion, Tablet, Gemcitabine, Dexamethasone
AB Science, AB Science
Relapsed or refractory peripheral T-cell lymphoma, Cancer of the white blood cells (T-lymphocytes), Diseases [C] - Cancer [C04]
 
 
NCT04442022 / 2020-000605-84: A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Recruiting
2/3
501
Europe, US, RoW
Selinexor (combination therapy), Placebo matching for Selinexor (combination therapy), Rituximab (combination therapy), Gemcitabine (combination therapy), Dexamethasone (combination therapy), Cisplatin (combination therapy), Selinexor (continuous therapy), Placebo matching for Selinexor (continuous therapy)
Karyopharm Therapeutics Inc
Relapsed/Refractory Diffuse Large B-cell Lymphoma
12/24
12/25
Glo-BNHL, NCT05991388: A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma

Not yet recruiting
2/3
210
NA
Odronextamab, REGN-1979, Loncastuximab tesirine, ADCT-402, Rituximab, Ifosfamide, Carboplatin, Etoposide, Etoposide Phosphate, Dexamethasone, CAR T-cells (TBC)
University of Birmingham, Cancer Research UK, Fight Kids Cancer, Regeneron Pharmaceuticals, ADC Therapeutics SA
B-cell Non Hodgkin Lymphoma
05/31
05/33

Download Options